--The European Commission has closed deals with pharmaceutical companies Roche and Merck KGaA for the supply of experimental Covid-19 drugs in any European member state, Reuters reports, citing an unnamed source.

--The drugs that will be supplied are Roche's RoActemra, a treatment for rheumatoid arthritis, and Merck's Rebif, an anti-inflammatory drug, Reuters reports.

--The terms of the deal aren't known, Reuters reports.

 

Full story: https://reut.rs/3iJ72Xl

 

Write to Barcelona editors at barcelonaeditors@dowjones.com

 

(END) Dow Jones Newswires

July 08, 2020 06:55 ET (10:55 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more Merck KGaA (PK) Charts.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more Merck KGaA (PK) Charts.